Table 3.
Work outcome | No. of studies | Pooled percentage [95% CI] | Heterogeneity [I2] |
---|---|---|---|
Employment | |||
Total IBD | 73 | 65.6% [61.9-69.3] | 99.7 |
CD only | 36 | 63.5% [57.9-69.0] | 99 |
UC only | 35 | 68.1% [64.9-73.3] | 99.6 |
Unemploymenta | |||
Total IBD | 51 | 16.4% [14.5-18.3] | 98.7 |
CD only | 22 | 15.2% [11.8-18.6] | 98 |
UC only | 25 | 13.0% [10.2-15.8] | 98.3 |
% reporting sick days | |||
Total IBD | 25 | 39.5% [16.8-62.3] | 99.9 |
CD only | 10 | 28.5% [22.8-34.2] | 99.3 |
UC only | 15 | 34.8% [5.1-64.5] | 99.9 |
% Disability due to IBD | |||
Total IBD | 28 | 21.3% [16.6-26.0] | 99.3 |
CD only | 16 | 21.0% [14.6-27.4] | 98.8 |
UC only | 15 | 17.8% [12.0-23.6] | 98.8 |
% Disability pensions | |||
Total IBD | 23 | 12.3% [10.7-13.9] | 96.7 |
CD only | 10 | 14.4% [12.0-16.8] | 95.2 |
UC only | 10 | 9.7% [6.4%-13.0] | 98.3 |
% losing jobs due to IBD | 4 | 29.6% [19.0-40.1] | |
Total IBD | 98.8 |
WPAI, Work Productivity and Activity Impairment questionnaire; IBD, inflammatory bowel disease; UC, ulcerative colitis; CD, Crohn’s disease.
aPatient employment data was not solely limited to employment vs unemployment. Accordingly, unemployment was analyzed as a separate outcome [as opposed to 1-employment]